Mary Helen Barcellos-Hoff
University of California, San Francisco
H-index: 66
North America-United States
Top articles of Mary Helen Barcellos-Hoff
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract B032: Compromised TGFβ signaling and DNA repair primes response to immune checkpoint inhibition by activating NK cells in immunologically cold breast cancers | Cancer Research | Jade Moore Jim Gkantalis Ines Guix Colin Foster Mary Helen Barcellos-Hoff | 2024/2/1 |
Lack of TGFβ signaling competency predicts immune poor cancer conversion to immune rich and response to checkpoint blockade | bioRxiv | Jade Moore Jim Gkantalis Inex Guix William Chou Kobe Yuen | 2024 |
Compromised TGFβ signaling and DNA repair primes immune poor tumors response to immune checkpoint blockade by activating NK cells | Cancer Research | Jade T Moore Jim Gkantalis Ines Guix Mary Helen Barcellos-Hoff | 2024/3/22 |
Lack of TGFβ signaling competency predicts conversion of immune poor cancer to immune rich and response to checkpoint blockade | bioRxiv | Jade Moore Jim Gkantalis Ines Guix William Chou Kobe Yuen | 2024/3/8 |
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer | Cell | Shrabanti Chowdhury Jacob J Kennedy Richard G Ivey Oscar D Murillo Noshad Hosseini | 2024/2/15 |
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference | Fabiana Gregucci Sheila Spada Mary Helen Barcellos-Hoff Nina Bhardwaj Charleen Chan Wah Hak | 2023/12/31 | |
DNA Damage Repair Deficit in Cancer Cells | 2023/11/2 | ||
Monitoring TGFβ signaling in irradiated tumors | Radiation Oncology and Radiotherapy Part C | Lin Ma Alba Gonzalez-Junca William Chou Mary Helen Barcellos-Hoff | 2023/10/25 |
Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy | Mary Helen Barcellos-Hoff James L Gulley | 2023/6/1 | |
The radiobiology of TGFβ | Mary Helen Barcellos-Hoff | 2022/11/1 | |
Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment | James L Gulley Jeffrey Schlom Mary Helen Barcellos‐Hoff Xiao‐Jing Wang Joan Seoane | 2022/6 | |
Table_5_From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer. xlsx [Dataset] | Hang Chang Xu Yang Jade Moore Xiao-Ping Liu Kuang-Yu Jen | 2022/2/15 | |
Mammary Tumor–Derived Transplants as Breast Cancer Models to Evaluate Tumor–Immune Interactions and Therapeutic Responses | Cancer research | Jade Moore Lin Ma Ann A Lazar Mary Helen Barcellos-Hoff | 2022/2/1 |
Validation of anticorrelated TGFβ signaling and alternative end-joining DNA repair signatures that predict response to genotoxic cancer therapy | Clinical Cancer Research | Ines Guix Qi Liu Miquel Angel Pujana Patrick Ha Josep Piulats | 2022/4/1 |
Exploiting canonical TGFβ signaling in cancer treatment | Qi Liu Genwen Chen Jade Moore Ines Guix Dimitris Placantonakis | 2022/1/1 | |
SRSF1 governs progenitor-specific alternative splicing to maintain adult epithelial tissue homeostasis and renewal | Developmental cell | Tingsheng Yu Oscar Cazares Alison D Tang Hyun-Yi Kim Tomas Wald | 2022/3/14 |
Positron emission tomography imaging of functional TGFβ activity and benefit of TGFβ Inhibition in irradiated intracranial tumors | International journal of radiation oncology, biology, physics | Alba Gonzalez-Junca Oliver Reiners Luis D Borrero-Garcia Denis Beckford-Vera Ann A Lazar | 2021/2/2 |
Cell Signaling Mediating Critical Radiation Responses | Carsten Herskind Mary Helen Barcellos-Hoff | 2021/5/10 | |
Abstract PO-049: TGFβ and PD-L1 inhibition in combination with radiotherapy can overcome glioblastoma resistance to immunotherapies | Clinical Cancer Research | Oliver Reiners Ann Lazar William Chou Hui Zhang Trevor Jones | 2021/4/15 |
Abstract IA-009: TGFβ regulation of DNA repair across cancer types predicts response to genotoxic therapies | Clinical Cancer Research | Mary Helen Barcellos-Hoff | 2021/4/15 |
Co-Authors
